Ra Pharmaceuticals to Present at the UBS 2017 Global Healthcare Conference

CAMBRIDGE, Mass.--()--Ra Pharmaceuticals, Inc. (NASDAQ: RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, PhD, President and Chief Executive Officer, will present at the UBS 2017 Global Healthcare Conference on Monday, May 22, 2017 at 10:00 a.m. E.T. The conference is being held at the Grand Hyatt New York.

The presentation will be webcast live and can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.

Contacts

Investors:
Ra Pharmaceuticals, Inc.
Jennifer Robinson, 617-674-9873
jrobinson@rapharma.com
or
Media:
Argot Partners
Eliza Schleifstein, 917-763-8106
eliza@argotpartners.com

Recent Stories

RSS feed for Ra Pharmaceuticals, Inc.

Ra Pharmaceuticals, Inc.